Dog allergy vaccine study for Swedish adults
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests an allergy shot (Alutard SQ Dog) for people with moderate to severe dog allergies. It aims to see how well the vaccine works in Swedish medical practices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You have moderate to severe allergy symptoms when around dogs.
- You have a confirmed dog allergy from a blood test.
- You do not currently own a dog.
- You are not pregnant, breastfeeding, or planning to become pregnant.
- You do not have serious health problems like autoimmune disease, heart disease, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat cat allergies by giving tiny injections directly into a lymph node (a part of your immune system), instead of under the skin. It aims to see if this method is safe and can reduce cat allergy symptoms, even in people with asthma.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This study tests if adding vitamin D to a new type of allergy shot (ILIT) works better than standard allergy drops for grass pollen allergy. It may help if you have moderate to severe seasonal allergy symptoms.
This study looks at lymph nodes in the neck to understand how the body responds to cat allergy treatments. It may help researchers improve allergy shots or other therapies for people with cat allergies.
This study tests an investigational injection (called JYB1904) to see if it helps reduce allergy symptoms from dust mites, pet dander, and other indoor allergens. It is for adults with moderate to severe allergic rhinitis (hay fever) who still have symptoms despite using a daily nasal steroid spray.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.